Lottery.com Inc. (SEGG)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.47	0.07	0.36	0.1	32.64	3.83
Cash & Short-Term Investments	0.47	0.07	0.36	0.1	32.64	3.83
Cash Growth	457.62%	-81.09%	250.14%	-99.69%	753.19%	2313.69%
Receivables	0.49	0.49	0.06	0.21	0.08	0.03
Prepaid Expenses	14.37	14.45	19.02	19.41	22.9	22.01
Restricted Cash	-	-	-	-	-	6.95
Other Current Assets	1.13	0.88	0.91	0.72	0.23	0.79
Total Current Assets	16.46	15.89	20.34	20.44	55.84	33.6
Property, Plant & Equipment	0	0.01	0.02	0.11	0.14	0.67
Long-Term Investments	0.25	0.25	0.25	0.25	0.25	0.25
Goodwill	9.06	9.06	11.23	19.59	19.59	13
Other Intangible Assets	12.78	12.57	17.68	23.98	28.71	3.21
Other Long-Term Assets	12.88	12.91	12.88	13.01	-	-
Total Assets	53.44	52.94	64.41	79.38	104.53	50.73
Accounts Payable	8.5	8.24	8.05	7.61	1.01	2.18
Accrued Expenses	12.54	13.72	12.22	5.11	4.59	3.06
Short-Term Debt	6.21	6.11	6.03	3.76	3.77	12.21
Current Portion of Long-Term Debt	-	-	-	-	-	8.88
Current Unearned Revenue	0.22	0.25	0.36	0.46	1.16	7.76
Other Current Liabilities	4.06	2.42	1.17	0.63	-	-
Total Current Liabilities	31.53	30.74	27.82	17.56	10.53	34.09
Long-Term Debt	-	-	-	-	-	0.01
Other Long-Term Liabilities	-	-	-	-	0	-
Total Liabilities	31.53	30.74	27.82	17.56	10.53	34.1
Common Stock	0.03	0.02	0	0	0.05	0.02
Additional Paid-In Capital	286.79	283.91	269.69	267.6	239.36	111.75
Retained Earnings	-266.78	-263.69	-235.13	-208.19	-148.19	-95.14
Comprehensive Income & Other	-0.18	0.02	-0.09	0	-0	-
Total Common Equity	19.86	20.25	34.47	59.42	91.22	16.63
Minority Interest	2.05	1.95	2.12	2.4	2.78	-
Shareholders' Equity	21.91	22.2	36.59	61.82	94	16.63
Total Liabilities & Equity	53.44	52.94	64.41	79.38	104.53	50.73
Total Debt	6.21	6.11	6.03	3.76	3.77	21.1
Net Cash (Debt)	-5.74	-6.04	-5.67	-3.65	28.87	-17.27
Net Cash Per Share	-0.42	-0.70	-2.18	-1.45	22.21	-15.25
Filing Date Shares Outstanding	26.7	18.86	4.78	2.54	2.54	5.16
Total Common Shares Outstanding	26.7	18.33	2.88	2.53	2.51	5.16
Working Capital	-15.07	-14.85	-7.48	2.88	45.31	-0.48
Book Value Per Share	0.74	1.11	11.98	23.51	36.30	3.22
Tangible Book Value	-1.98	-1.38	5.56	15.84	42.92	0.43
Tangible Book Value Per Share	-0.07	-0.08	1.93	6.27	17.08	0.08
Machinery	-	0.14	0.14	0.14	0.14	0.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q